Mepivicaine is one of 2 small molecule programs targeting Supraclavicular Brachial Plexus Block. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
1 competitor in Supraclavicular Brachial Plexus Block
Lidocaine Mixed With Epinephrine
Mepivicaine
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details